CClinicalTrials.gg
CompletedNCT03962309SKIMUpdated May 7, 2025

Selection of People at Low Cardiovascular Risk: Development of an Inexpensive Pre-screening Algorithm Using Only Non-laboratory Measures. The SKIM Risk Study.

An observational study in Epidemiology of Cardiovascular Risk, sponsored by Mario Negri Institute for Pharmacological Research. Completed at 3 sites in Italy. Open to participants aged 40 Years to 69 Years. Per ClinicalTrials.gov, last updated 2025-05-07.

Sponsored by Mario Negri Institute for Pharmacological Research · Observational

Study type
Observational
Model
Cohort
Time perspective
Cross-sectional
Enrollment
2,699
Ages
40 Years to 69 Years
Sex
All
01

Study summary

Early identification of individuals at high risk remains the cornerstone of primary cardiovascular prevention (CV). However, cardiovascular screening including people at low CV diseases (CVD) risk are too costly, time consuming and poorly effective in reducing incident CV events to be proposed at population level. Thus, innovative tools that allow to exclude low risk subjects in order to concentrate the relatively poor resources of NHS for primary prevention in high risk groups are needed. In this study, we will assess whether a new low cost strategy for CV risk stratification, based on non-laboratory measures, will allow to recognize low risk subjects who do not need further and expensive measures. To this end, we will take advantage of a General Practitioners (GPs) national network that will allow to work in the natural contest of primary prevention. If successful, the project will provide the basis for future, cost-effective prevention programs to be performed at national level.

Read the detailed description

National, multicenter cross-sectional study.

The current study will be performed as part of Italian Cardiology Network implemented by the Italian Ministry of Health.

This study will be carried out with the collaboration with Study Center for Primary Care.

A random sample of subjects identified by the list of patients in charge of the participating GPs aged 40-70 years will be invited to a screening for the evaluation of their CV risk.

All patients who agree to participate in the study and sign the consent will complete a health self-assessment questionnaire which includes questions covering anthropometric, sociodemographics, personal and family health history, life style habits and aspects of the behavioral domain.

This will be followed by biometric measurements including height, weight and waist circumference conducted at the consulting room of the GP by certified staff. Informative predictors, selected among all variables selected, will be identified by a stepwise multivariable logistic regression. The low risk CV score will be calculated as the sum of the coefficients of the retained variables.

02

Conditions studied

  • Epidemiology of Cardiovascular Risk

Keywords

  • Screening
  • General Practice
  • Self Assessment
  • Algorithms for risk stratification
03

In context

Lead sponsor

Mario Negri Institute for Pharmacological Research is the lead sponsor of 159 studies on the registry; 36 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
40 Years to 69 Years
Sexes eligible
All
Accepts healthy volunteers
No
Sampling method
Non-probability sample

Study population

Subjects aged 40-70 years in charge of GPs, giving the consent to partecipate in the study

Inclusion criteria

  • Subjects aged 40-70 years

Exclusion criteria

Exclusion Criteria:

  • Patients with previous cardiovascular events
05

Study design

Observational model
Cohort
Time perspective
Cross-sectional
Enrollment
2,699 participants (actual)
Patient registry
No

Groups and cohorts

  • Patients in charge of the participating GPs

    In the study will be included patients in charge of the participating GPs aged 40-70 years

    Other: Health self-assessment questionnaire

Interventions

  • OtherHealth self-assessment questionnaire

    The health self-assessment questionnaire includes questions covering anthropometric, sociodemographics, personal and family health history, life style habits and aspects of the behavioral domain. The questionnaire will be administered as paper format or web-based electronic format according to participants' preferences.

06

What researchers measure

Primary outcomes

  1. To develop of a low cost CVD risk score

    The low cost CVD risk score will be developed using variable obtainable only by the self-assessment questionnaire (low-cost) to identify persons at low CVD risk according to Progetto CUORE or SCORE risk estimation.

    Time frame: 1 day

Secondary outcomes

  1. Race

    Questions about the ethnic origin will be asked

    Time frame: 1 day

  2. Marital status

    Questions about the marital status will be asked

    Time frame: 1 day

  3. Education status

    Questions about the educational attainment will be asked

    Time frame: 1 day

  4. Employment status

    Questions about the employment will be asked

    Time frame: 1 day

  5. Clinical Family History

    Questions about the family health history will be asked

    Time frame: 1 day

  6. Personal Clinical History

    Questions about the personal health history will be asked

    Time frame: 1 day

  7. The dietary habits

    Questions about diet, alcohol consumption and salt consumption will be asked.

    Time frame: 1 day

  8. Physical activity

    Questions about physical activity usually practiced will be asked

    Time frame: 1 day

  9. Smoking habits

    Questions about smoking habits will be asked

    Time frame: 1 day

  10. Behavioral domain

    Questions about aspects of the behavioral domain will be asked

    Time frame: 1 day

07

Study locations

3 sites
  • Cooperativa Medici Milano Centro
    Milano, Italy
  • Cooperativa Nucleo Cure Primarie Val Pescara
    Pescara, Italy
  • Cooperativa Medici 2000
    Siena, Italy
08

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on May 7, 2025, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
09

Registry details

Key details

Study ID
NCT03962309
Lead sponsor
Mario Negri Institute for Pharmacological Research
Collaborators
Centro Cardiologico Monzino, IRCCS Multimedica
Responsible party
Sponsor
First posted
May 24, 2019
Start date
Dec 18, 2020
Primary completion
Jun 30, 2024
Completion
Aug 31, 2024
Last update
May 7, 2025

Study contacts

Roberto Latini, MD
principal investigator · Istituto Di Ricerche Farmacologiche Mario Negri

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in May 2025. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion